http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101606302-B1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-143333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-085 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4724 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-473 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57438 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
filingDate | 2010-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2016-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-101606302-B1 |
titleOfInvention | Method for measurement of glycoprotein, method for detection of hepatic diseases, reagent for quantification of glycoprotein, and sugar chain marker glycoprotein as measure of disease conditions of hepatic diseases |
abstract | It is an object of the present invention to provide a method for measuring glycoconjugate glycoprotein capable of detecting liver disease with higher accuracy than the conventional method. It is another object of the present invention to provide a method for examining a liver disease capable of detecting liver disease with higher precision than the conventional method. It is another object of the present invention to provide a reagent for quantitatively determining a glycoprotein used in the above-mentioned measurement method. It is another object of the present invention to provide a glycoprotein glycoprotein marker glycoprotein marker capable of discriminating liver disease conditions according to progress of liver disease. A method for measuring at least one glycoprotein selected from alpha-1-acid glycoprotein (AGP) and Mac-2-binding protein (M2BP) contained in a sample collected from a subject, And M2BP binding to a second lectin selected from WFA, BPL, AAL, RCA120, and TJAII when the glycoprotein is M2BP is measured. do. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3816629-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20210052751-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11493521-B2 |
priorityDate | 2009-07-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 241.